Research Article 
Psychological status of Chinese patients with Type 2 diabetes: data review of Diabcare-China studies
C. Pan, W. Yang, W. Jia, J. Weng, G. Liu, B. Luo, X. Li, Z. Fu and H. Tian
Diabetic Medicine, 2012, 29(4), 515-521. DOI: 10.1111/j.1464-5491.2011.03436.x
Abstract
Aim To describe the status of glycaemic control, self-reported adherence to treatments, psychological well-being and quality of life in Chinese patients with Type 2 diabetes in 2006.
Methods Subjects having registered for care for > 12 months at a diabetes clinic were enrolled in this study. Glycaemic control was determined by HbA1c and plasma glucose levels; information about self-reported adherence to treatments was obtained by questionnaire; psychological well-being was assessed by use of a modified World Health Organization-5 Well-being Index; and quality of life was measured by use of a modified Diabetes Attitudes, Wishes and Needs (DAWN) survey. All data were tabulated and statistical analyses were performed.
Results A total of 2702 patients were enrolled during 2006. Only 23% of patients achieved an HbA1c level of < 48 mmol/mol (6.5%) as per the 2007 China guideline for Type 2 diabetes and only 16.2% followed all treatment recommendations from healthcare providers. Of the patients, 46.0-68.6% of the patients showed positive psychological well-being. A quality-of-life survey showed that 28.5-50.6% of the patients experienced various diabetes-related emotional problems. Large percentages (approximately 50%) of patients were experiencing psychological insulin resistance.
Conclusions Although in China therapies for Type 2 diabetes are more effective and available than ever before, the patient outcomes remain disappointing. Problems with glycaemic control, self-reported adherence to treatments, psychological well-being and quality of life, all of which are key to diabetes control, are common among Chinese patients with Type 2 diabetes.
ASCI-ID: 109-1022
Similar Articles
Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes
Diabetic Medicine, 2007, 24(6), 607-617. DOI: 10.1111/j.1464-5491.2007.02120.x
Health utility values associated with diabetic retinopathyDiabetic Medicine, 2008, 25(5), 618-624. DOI: 10.1111/j.1464-5491.2008.02430.x
Investigation of quality of life and family burden issues during insulin pump therapy in children with Type 1 diabetes mellitus—a large-scale multicentre pilot study1Diabetic Medicine, 2009, 26(5), 493-501. DOI: 10.1111/j.1464-5491.2009.02707.x
Patient-reported outcomes following islet cell or pancreas transplantation (alone or after kidney) in Type 1 diabetes: a systematic reviewDiabetic Medicine, 2010, 27(7), 812-822. DOI: 10.1111/j.1464-5491.2010.03029.x
Initiation of insulin glargine in patients with Type 2 diabetes in suboptimal glycaemic control positively impacts health-related quality of life. A prospective cohort study in primary careDiabetic Medicine, 2011, 28(9), 1096-1102. DOI: 10.1111/j.1464-5491.2011.03329.x
Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injectionsDiabetic Medicine, 2008, 25(2), 213-220. DOI: 10.1111/j.1464-5491.2007.02346.x
Quality of life in children with Type 1 diabetes: a comparison of general and diabetes-specific measures and support for a unitary diabetes quality-of-life constructDiabetic Medicine, 2008, 25(11), 1316-1323. DOI: 10.1111/j.1464-5491.2008.02574.x
Not all roads lead to Rome-a review of quality of life measurement in adults with diabetesDiabetic Medicine, 2009, 26(4), 315-327. DOI: 10.1111/j.1464-5491.2009.02682.x
Randomized trial of custom orthoses and footwear on foot pain and plantar pressure in diabetic peripheral arterial diseaseDiabetic Medicine, 2009, 26(9), 893-899. DOI: 10.1111/j.1464-5491.2009.02799.x
Prevalence of pain and association with quality of life, depression and glycaemic control in patients with diabetesDiabetic Medicine, 2010, 27(5), 578-584. DOI: 10.1111/j.1464-5491.2010.02971.x
People living with diabetes resident in nursing homes-assessing levels of disability and nursing needsDiabetic Medicine, 2011, 28(7), 778-780. DOI: 10.1111/j.1464-5491.2011.03261.x
The impact of hypoglycaemia on quality of life and related patient-reported outcomes in Type 2 diabetes: a narrative reviewDiabetic Medicine, 2012, 29(3), 293-302. DOI: 10.1111/j.1464-5491.2011.03416.x
Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetesDiabetic Medicine, 2012, 29(6), 716-720. DOI: 10.1111/j.1464-5491.2011.03547.x
Variability of lipids in patients with Type 2 diabetes taking statin treatment: implications for target settingDiabetic Medicine, 2008, 25(8), 909-915.
Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients-The PREDICTIVETM BMI clinical trial1Diabetic Medicine, 2008, 25(8), 916-923.
Weight history of patients with newly diagnosed Type 2 diabetesDiabetic Medicine, 2008, 25(8), 933-941.
Educational interventions for migrant South Asians with Type 2 diabetes: a systematic reviewDiabetic Medicine, 2008, 25(8), 985-992.
Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxidesDiabetic Medicine, 2008, 25(9), 1049-1055. DOI: 10.1111/j.1464-5491.2008.02546.x
The islet autoantibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitusDiabetic Medicine, 2008, 25(2), 117-125. DOI: 10.1111/j.1464-5491.2007.02316.x
Variable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutationDiabetic Medicine, 2008, 25(6), 651-656. DOI: 10.1111/j.1464-5491.2008.02443.x
The effect of the availability of inhaled insulin on glycaemic control in patients with Type 2 diabetes failing on oral therapy: the evaluation of Exubera® as a therapeutic option on insulin initiation and improvement in glycaemic control in clinical practice EXPERIENCE) trialDiabetic Medicine, 2008, 25(6), 662-670. DOI: 10.1111/j.1464-5491.2008.02438.x
Prevalence and reasons for insulin refusal in Bangladeshi patients with poorly controlled Type 2 diabetes in East LondonDiabetic Medicine, 2008, 25(9), 1108-1111. DOI: 10.1111/j.1464-5491.2008.02538.x
Development of alternative methods of data collection in South Asians with Type 2 diabetesDiabetic Medicine, 2008, 25(4), 455-462. DOI: 10.1111/j.1464-5491.2008.02401.x
A new era in finding Type 2 diabetes genes—the unusual suspectsDiabetic Medicine, 2007, 24(7), 696-701. DOI: 10.1111/j.1464-5491.2007.02172.x
A randomized controlled trial examining combinations of repaglinide, metformin and NPH insulinDiabetic Medicine, 2007, 24(7), 714-719. DOI: 10.1111/j.1464-5491.2007.02128.x
The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in AustraliaDiabetic Medicine, 2007, 24(6), 677-683. DOI: 10.1111/j.1464-5491.2007.02143.x
No evidence for increased self-reported cognitive failure in Type 1 and Type 2 diabetes: a cross-sectional studyDiabetic Medicine, 2007, 24(7), 735-740. DOI: 10.1111/j.1464-5491.2007.02153.x
Living with Type 2 diabetes: a family perspectiveDiabetic Medicine, 2007, 24(7), 796-801. DOI: 10.1111/j.1464-5491.2007.02171.x
Vibrotactile sense in median and ulnar nerve innervated fingers of men with Type 2 diabetes, normal or impaired glucose toleranceDiabetic Medicine, 2008, 25(5), 543-549. DOI: 10.1111/j.1464-5491.2008.02433.x
Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in Type 2 diabetes1Diabetic Medicine, 2008, 25(5), 585-591. DOI: 10.1111/j.1464-5491.2008.02418.x
The association of physical activity and depression in Type 2 diabetesDiabetic Medicine, 2008, 25(10), 1133-1141. DOI: 10.1111/j.1464-5491.2008.02545.x
Effect of weight-reducing agents on glycaemic parameters and progression to Type 2 diabetes: a reviewDiabetic Medicine, 2008, 25(10), 1142-1150. DOI: 10.1111/j.1464-5491.2008.02550.x
Prevalence and incidence of Type 2 diabetes and its complications 1996-2003-estimates from a Swedish population-based studyDiabetic Medicine, 2008, 25(10), 1178-1186. DOI: 10.1111/j.1464-5491.2008.02541.x
Psychosocial factors are independent risk factors for the development of Type 2 diabetes in Japanese workers with impaired fasting glucose and/or impaired glucose toleranceDiabetic Medicine, 2008, 25(10), 1211-1217. DOI: 10.1111/j.1464-5491.2008.02566.x
Self-monitoring of blood glucose changed non-insulin-treated Type 2 diabetes patients' beliefs about diabetes and self-monitoring in a randomized trialDiabetic Medicine, 2008, 25(10), 1218-1228. DOI: 10.1111/j.1464-5491.2008.02569.x
The Y402H variant of complement factor H is associated with age-related macular degeneration but not with diabetic retinal disease in the Go-DARTS studyDiabetic Medicine, 2009, 26(5), 460-465. DOI: 10.1111/j.1464-5491.2009.02719.x
Relationship of Type 2 diabetes to the prevalence, incidence and progression of age-related hearing lossDiabetic Medicine, 2009, 26(5), 483-488. DOI: 10.1111/j.1464-5491.2009.02710.x
Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivityDiabetic Medicine, 2009, 26(5), 526-531. DOI: 10.1111/j.1464-5491.2009.02727.x
Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipidsDiabetic Medicine, 2009, 26(5), 532-539. DOI: 10.1111/j.1464-5491.2009.02729.x
Investigation of the effect of oral metformin on dipeptidylpeptidase-4 (DPP-4) activity in Type 2 diabetesDiabetic Medicine, 2009, 26(6), 649-654. DOI: 10.1111/j.1464-5491.2009.02748.x
Relative and absolute contributions of postprandial and fasting plasma glucose to daytime hyperglycaemia and HbA1c in subjects with Type 2 diabetesDiabetic Medicine, 2009, 26(10), 974-980. DOI: 10.1111/j.1464-5491.2009.02809.x
Clinical factors associated with gait alterations in diabetic patientsDiabetic Medicine, 2009, 26(10), 1003-1009. DOI: 10.1111/j.1464-5491.2009.02811.x
Long-term glycaemic control with metformin–sulphonylurea–pioglitazone triple therapy in PROactive (PROactive 17)Diabetic Medicine, 2009, 26(10), 1033-1039. DOI: 10.1111/j.1464-5491.2009.02816.x
Can peer educators influence healthy eating in people with diabetes? Results of a randomized controlled trialDiabetic Medicine, 2009, 26(10), 1048-1054. DOI: 10.1111/j.1464-5491.2009.02808.x
Long-term glycaemic effects of pioglitazone compared with placebo as add-on treatment to metformin or sulphonylurea monotherapy in PROactive (PROactive 18)Diabetic Medicine, 2009, 26(12), 1242-1249. DOI: 10.1111/j.1464-5491.2009.02857.x
Incidence of Type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort studyDiabetic Medicine, 2009, 26(12), 1212-1219. DOI: 10.1111/j.1464-5491.2009.02863.x
Efficacy and safety of insulin glargine and glimepiride in subjects with Type 2 diabetes before, during and after the period of fasting in RamadanDiabetic Medicine, 2009, 26(12), 1255-1261. DOI: 10.1111/j.1464-5491.2009.02836.x
Does an advanced insulin education programme improve outcomes and health service use for people with Type 2 diabetes? A 5-year follow-up of the Newcastle Empowerment courseDiabetic Medicine, 2009, 26(12), 1277-1281. DOI: 10.1111/j.1464-5491.2009.02858.x
The effect of rosiglitazone on insulin sensitivity and mid-thigh low-density muscle in patients with Type 2 diabetesDiabetic Medicine, 2010, 27(1), 30-36. DOI: 10.1111/j.1464-5491.2009.02897.x
Independent predictive roles of eotaxin Ala23Thr, paraoxonase 2 Ser311Cys and β3-adrenergic receptor Trp64Arg polymorphisms on cardiac disease in Type 2 Diabetes-an 8-year prospective cohort analysis of 1297 patientsDiabetic Medicine, 2010, 27(4), 376-383. DOI: 10.1111/j.1464-5491.2010.02980.x
The prevalence of retinopathy in men with Type 2 diabetes and obstructive sleep apnoeaDiabetic Medicine, 2010, 27(4), 423-430. DOI: 10.1111/j.1464-5491.2010.02962.x
Implementation and effectiveness of the first community lifestyle intervention programme to prevent Type 2 diabetes in Greece. The DE-PLAN studyDiabetic Medicine, 2010, 27(4), 459-465. DOI: 10.1111/j.1464-5491.2010.02918.x
Diabetes Care Protocol: effects on patient-important outcomes. A cluster randomized, non-inferiority trial in primary careDiabetic Medicine, 2010, 27(4), 442-450. DOI: 10.1111/j.1464-5491.2010.02968.x
Culturally appropriate health education for Type 2 diabetes in ethnic minority groups: a systematic and narrative review of randomized controlled trialsDiabetic Medicine, 2010, 27(6), 613-623. DOI: 10.1111/j.1464-5491.2010.02954.x
Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a national health insurance data set studyDiabetic Medicine, 2010, 27(6), 636-643. DOI: 10.1111/j.1464-5491.2010.03007.x
Is risk of diabetic retinopathy lower in Australia’s Greek-born migrants?Diabetic Medicine, 2010, 27(6), 660-665. DOI: 10.1111/j.1464-5491.2010.03005.x
Diabetes-specific emotional distress mediates the association between depressive symptoms and glycaemic control in Type 1 and Type 2 diabetesDiabetic Medicine, 2010, 27(7), 798-803. DOI: 10.1111/j.1464-5491.2010.03025.x
High-cocoa polyphenol-rich chocolate improves HDL cholesterol in Type 2 diabetes patientsDiabetic Medicine, 2010, 27(11), 1318-1321. DOI: 10.1111/j.1464-5491.2010.03108.x
Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetesDiabetic Medicine, 2010, 27(2), 175-180. DOI: 10.1111/j.1464-5491.2009.02915.x
A randomized, treat-to-target trial comparing insulin lispro protamine suspension and insulin detemir in insulin-naive patients with Type 2 diabetesDiabetic Medicine, 2010, 27(2), 181-188. DOI: 10.1111/j.1464-5491.2009.02899.x
Type 2 diabetes as an ‘infectious’ disease: is this the Black Death of the 21st century?Diabetic Medicine, 2011, 28(1), 2-9. DOI: 10.1111/j.1464-5491.2010.03167.x
HbA1c in diagnosing and predicting Type 2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention StudyDiabetic Medicine, 2011, 28(1), 36-42. DOI: 10.1111/j.1464-5491.2010.03183.x
The potential for a two-stage diabetes risk algorithm combining non-laboratory-based scores with subsequent routine non-fasting blood tests: results from prospective studies in older men and womenDiabetic Medicine, 2011, 28(1), 23-30. DOI: 10.1111/j.1464-5491.2010.03171.x
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation is less accurate in patients with Type 2 diabetes when compared with healthy individualsDiabetic Medicine, 2011, 28(1), 90-95. DOI: 10.1111/j.1464-5491.2010.03161.x
Low serum bilirubin concentration in haemodialysis patients with Type 2 diabetesDiabetic Medicine, 2011, 28(1), 96-99. DOI: 10.1111/j.1464-5491.2010.03173.x
Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatinDiabetic Medicine, 2011, 28(1), 100-108. DOI: 10.1111/j.1464-5491.2010.03139.x
Factors associated with medication adherence to oral hypoglycaemic agents in different ethnic groups suffering from Type 2 diabetes: a systematic literature review and suggestions for further researchDiabetic Medicine, 2011, 28(3), 262-275. DOI: 10.1111/j.1464-5491.2010.03133.x
Effect of subsequent pregnancies on the risk of developing diabetes following a first pregnancy complicated by gestational diabetes: a population-based studyDiabetic Medicine, 2011, 28(3), 287-292. DOI: 10.1111/j.1464-5491.2010.03179.x
Plasma levels of glucagon like peptide-1 associate with diastolic function in elderly menDiabetic Medicine, 2011, 28(3), 301-305. DOI: 10.1111/j.1464-5491.2010.03207.x
Improved quality of Type 2 diabetes care following electronic feedback of treatment status to general practitioners: a cluster randomized controlled trialDiabetic Medicine, 2011, 28(3), 325-332. DOI: 10.1111/j.1464-5491.2010.03178.x
Liraglutide improves treatment satisfaction in people with Type 2 diabetes compared with sitagliptin, each as an add on to metforminDiabetic Medicine, 2011, 28(3), 333-337. DOI: 10.1111/j.1464-5491.2010.03074.x
Obstetric and perinatal outcomes in pregnancies complicated by Type 1 and Type 2 diabetes: influences of glycaemic control, obesity and social disadvantageDiabetic Medicine, 2011, 28(9), 1060-1067. DOI: 10.1111/j.1464-5491.2011.03333.x
Economic impact of moderate weight loss in patients with Type 2 diabetes: The Fremantle Diabetes StudyDiabetic Medicine, 2011, 28(9), 1131-1135. DOI: 10.1111/j.1464-5491.2011.03314.x
Does Vitamin D deficiency play a role in peripheral neuropathy in Type 2 diabetes?Diabetic Medicine, 2012, 29(1), 43-49. DOI: 10.1111/j.1464-5491.2011.03510.x
Serum adiponectin, bone mineral density and bone turnover markers in post-menopausal women with newly diagnosed Type 2 diabetes: a 12-month follow-upDiabetic Medicine, 2012, 29(1), 62-69. DOI: 10.1111/j.1464-5491.2011.03381.x
Reduction in glycated albumin can predict change in HbA1c: comparison of oral hypoglycaemic agent and insulin treatmentsDiabetic Medicine, 2012, 29(1), 74-79. DOI: 10.1111/j.1464-5491.2011.03386.x
Validation of a single-sample urinary C-peptide creatinine ratio as a reproducible alternative to serum C-peptide in patients with Type 2 diabetesDiabetic Medicine, 2012, 29(1), 90-93. DOI: 10.1111/j.1464-5491.2011.03428.x
Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerance—analysis of the Indian Diabetes Prevention ProgrammesDiabetic Medicine, 2012, 29(1), 94-98. DOI: 10.1111/j.1464-5491.2011.03392.x
Two risk score models for predicting incident Type 2 diabetes in JapanDiabetic Medicine, 2012, 29(1), 107-114. DOI: 10.1111/j.1464-5491.2011.03376.x
Effect of psychological stress on glucose control in patients with Type 2 diabetesDiabetic Medicine, 2012, 29(1), 128-131. DOI: 10.1111/j.1464-5491.2011.03431.x
Analysis of 32 common susceptibility genetic variants and their combined effect in predicting risk of Type 2 diabetes and related traits in IndiansDiabetic Medicine, 2012, 29(1), 121-127. DOI: 10.1111/j.1464-5491.2011.03438x
Effect of RBP4 gene variants on circulating RBP4 concentration and Type 2 diabetes in a Chinese populationDiabetic Medicine, 2008, 25(1), 11-18. DOI: 10.1111/j.1464-5491.2007.02314.x
The locus of control in patients with Type 1 and Type 2 diabetes managed by individual and group careDiabetic Medicine, 2008, 25(1), 86-90. DOI: 10.1111/j.1464-5491.2007.02319.x
Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patientsDiabetic Medicine, 2008, 25(2), 174-178. DOI: 10.1111/j.1464-5491.2007.02379.x
Paraoxonase 1 phenotype distribution and activity differs in subjects with newly diagnosed Type 2 diabetes (the CODAM Study)Diabetic Medicine, 2008, 25(2), 186-193. DOI: 10.1111/j.1464-5491.2007.02328.x
Preserved heart rate variability in first-degree relatives of subjects with Type 2 diabetes mellitus without metabolic disordersDiabetic Medicine, 2008, 25(3), 355-359. DOI: 10.1111/j.1464-5491.2007.02364.x
Symptoms of depression in people with impaired glucose metabolism or Type 2 diabetes mellitus: The Hoorn StudyDiabetic Medicine, 2008, 25(7), 843-849. DOI: 10.1111/j.1464-5491.2008.02464.x
Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16Diabetic Medicine, 2008, 25(12), 1426-1432. DOI: 10.1111/j.1464-5491.2008.02592.x
The metabolic syndrome is related to albuminuria in Type 2 diabetesDiabetic Medicine, 2008, 25(12), 1412-1418. DOI: 10.1111/j.1464-5491.2008.02603.x
Dorothy Hodgkin Lecture 2008 Gastric inhibitory polypeptide (GIP) revisited: a new therapeutic target for obesity-diabetes?Diabetic Medicine, 2008, 25(7), 759-764. DOI: 10.1111/j.1464-5491.2008.02455.x
The impact of different time frames of risk communication on Type 2 diabetes patients' understanding and memory for risk of coronary heart disease and strokeDiabetic Medicine, 2008, 25(7), 811-817. DOI: 10.1111/j.1464-5491.2008.02473.x
Psychological distress and risk of pre-diabetes and Type 2 diabetes in a prospective study of Swedish middle-aged men and womenDiabetic Medicine, 2008, 25(7), 834-842. DOI: 10.1111/j.1464-5491.2008.02463.x
Ketoacidosis occurs in both Type 1 and Type 2 diabetes- a population-based study from Northern SwedenDiabetic Medicine, 2008, 25(7), 867-870. DOI: 10.1111/j.1464-5491.2008.02461.x
Hypoglycaemia in Type 2 diabetesDiabetic Medicine, 2008, 25(3), 245-254. DOI: 10.1111/j.1464-5491.2007.02341.x
Does serum 1,5-anhydroglucitol establish a relationship between improvements in HbA1c and postprandial glucose excursions? Supportive evidence utilizing the differential effects between biphasic insulin aspart 30 and insulin glargineDiabetic Medicine, 2008, 25(2), 200-205. DOI: 10.1111/j.1464-5491.2008.02384.x
The association of genetic variants in Kruppel-like factor 11 and Type 2 diabetes in the Japanese populationDiabetic Medicine, 2008, 25(1), 19-26. DOI: 10.1111/j.1464-5491.2007.02315.x
Cardiovascular risk profile of subjects with known diabetes from the middle- and high-income group population of Delhi: the DEDICOM surveyDiabetic Medicine, 2008, 25(1), 27-36. DOI: 10.1111/j.1464-5491.2007.02307.x
Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patientsDiabetic Medicine, 2008, 25(1), 45-50. DOI: 10.1111/j.1464-5491.2007.02327.x
Interactive effect of central obesity and hypertension on cognitive function in older out-patients with Type 2 diabetesDiabetic Medicine, 2008, 25(12), 1440-1446. DOI: 10.1111/j.1464-5491.2008.02612.x
Life-course socio-economic position, area deprivation and Type 2 diabetes: findings from the British Women's Heart and Health StudyDiabetic Medicine, 2008, 25(12), 1462-1468. DOI: 10.1111/j.1464-5491.2008.02594.x
Effect of cranberry extracts on lipid profiles in subjects with Type 2 diabetesDiabetic Medicine, 2008, 25(12), 1473-1477. DOI: 10.1111/j.1464-5491.2008.02588.x
Healthcare charges and utilization associated with diabetic neuropathy: impact of Type 1 diabetes and presence of other diabetes-related complications and comorbiditiesDiabetic Medicine, 2009, 26(1), 61-69. DOI: 10.1111/j.1464-5491.2008.02616.x
A randomized trial investigating the 12-month changes in physical activity and health outcomes following a physical activity consultation delivered by a person or in written form in Type 2 diabetes: Time2ActDiabetic Medicine, 2009, 26(3), 293-301. DOI: 10.1111/j.1464-5491.2009.02675.x
Association between plasma osteoprotegerin concentrations and urinary albumin excretion in Type 2 diabetesDiabetic Medicine, 2009, 26(4), 397-403. DOI: 10.1111/j.1464-5491.2009.02683.x
European physicians overestimate life expectancy and the likely impact of interventions in individuals with Type 2 diabetesDiabetic Medicine, 2009, 26(4), 453-455. DOI: 10.1111/j.1464-5491.2009.02702.x
Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetesDiabetic Medicine, 2009, 26(7), 665-672. DOI: 10.1111/j.1464-5491.2009.02759.x
The effect of anti-inflammatory (aspirin and/or statin) therapy on body weight in Type 2 diabetic individuals: EAT, a retrospective studyDiabetic Medicine, 2009, 26(7), 708-713. DOI: 10.1111/j.1464-5491.2009.02747.x
J-shaped relationship between waist circumference and subsequent risk for Type 2 diabetes: an 8-year follow-up of relatively lean Japanese individualsDiabetic Medicine, 2009, 26(8), 753-759. DOI: 10.1111/j.1464-5491.2009.02773.x
Evidence of an accelerating increase in prevalence of diagnosed Type 2 diabetes in British men, 1978-2005Diabetic Medicine, 2009, 26(8), 766-772. DOI: 10.1111/j.1464-5491.2009.02768.x
Prescription charge exemption and Type 2 diabetes mellitus - a survey of diabetologists' understandingDiabetic Medicine, 2009, 26(8), 827-828. DOI: 10.1111/j.1464-5491.2009.02764.x
Morphological comparison of small nerve fibres in gastric mucosa in non-diabetic and Type 2 diabetic subjectsDiabetic Medicine, 2009, 26(9), 943-946. DOI: 10.1111/j.1464-5491.2009.02787.x
N-terminal pro-B-type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patientsDiabetic Medicine, 2009, 26(9), 872-879. DOI: 10.1111/j.1464-5491.2009.02788.x
Adherence to a Mediterranean diet and glycaemic control in Type 2 diabetes mellitusDiabetic Medicine, 2009, 26(9), 900-907. DOI: 10.1111/j.1464-5491.2009.02798.x
Carotid intima-media thickness and apolipoprotein B/apolipoprotein A-I ratio in middle-aged patients with Type 2 diabetesDiabetic Medicine, 2009, 26(4), 384-390. DOI: 10.1111/j.1464-5491.2009.02693.x
The threshold for definition of impaired fasting glucose in a Japanese populationDiabetic Medicine, 2009, 26(11), 1175-1178. DOI: 10.1111/j.1464-5491.2009.02850.x
A comparison of efficacy and safety of vildagliptin and gliclazide in combination with metformin in patients with Type 2 diabetes inadequately controlled with metformin alone: a 52-week, randomized studyDiabetic Medicine, 2010, 27(3), 318-326. DOI: 10.1111/j.1464-5491.2010.02938.x
Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during RamadanDiabetic Medicine, 2010, 27(3), 327-331. DOI: 10.1111/j.1464-5491.2010.02948.x
Type 2 diabetes in Canada: concentration of risk among most disadvantaged men but inverse social gradient across groups in womenDiabetic Medicine, 2010, 27(5), 522-531. DOI: 10.1111/j.1464-5491.2010.02982.x
Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled studyDiabetic Medicine, 2010, 27(5), 556-562. DOI: 10.1111/j.1464-5491.2010.02990.x
First diabetes prevalence study in Portugal: PREVADIAB studyDiabetic Medicine, 2010, 27(8), 879-881. DOI: 10.1111/j.1464-5491.2010.03017.x
Perceived risk of Type 2 diabetes in Australian women with a recent history of gestational diabetes mellitusDiabetic Medicine, 2010, 27(8), 882-886. DOI: 10.1111/j.1464-5491.2010.03032.x
Painful foot drop; a presentation of diabetic muscle infarctionDiabetic Medicine, 2010, 27(8), 958-959. DOI: 10.1111/j.1464-5491.2010.03060.x
Depressive symptoms in the first year from diagnosis of Type 2 diabetes: results from the DESMOND trialDiabetic Medicine, 2010, 27(8), 965-967. DOI: 10.1111/j.1464-5491.2010.03028.x
Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge studyDiabetic Medicine, 2010, 27(9), 995-1003. DOI: 10.1111/j.1464-5491.2010.03056.x
Safe and rapid resolution of severe hypertriglyceridaemia in two patients with intravenous insulinDiabetic Medicine, 2010, 27(9), 1080-1083. DOI: 10.1111/j.1464-5491.2010.03036.x
Metformin action on AMP-activated protein kinase: a translational research approach to understanding a potential new therapeutic targetDiabetic Medicine, 2010, 27(10), 1097-1106. DOI: 10.1111/j.1464-5491.2010.03098.x
Are there differences in cardiovascular and metabolic risk profiles among men and women with Type 2 diabetes? A cross-sectional analysisDiabetic Medicine, 2010, 27(10), 1212-1214. DOI: 10.1111/j.1464-5491.2010.03077.x
Risk equations to predict life expectancy of people with Type 2 diabetes mellitus following major complications: a study from Western AustraliaDiabetic Medicine, 2011, 28(4), 428-435. DOI: 10.1111/j.1464-5491.2010.03189.x
High sodium and low potassium intake in patients with Type 2 diabetesDiabetic Medicine, 2010, 27(12), 1401-1408. DOI: 10.1111/j.1464-5491.2010.03111.x
Association of the POU class 2 homeobox 1 gene (POU2F1) with susceptibility to Type 2 diabetes in Chinese populationsDiabetic Medicine, 2010, 27(12), 1443-1449. DOI: 10.1111/j.1464-5491.2010.03124.x
A 12-year follow-up study of all-cause and cardiovascular mortality among 10 532 people newly diagnosed with Type 2 diabetes in Tayside, ScotlandDiabetic Medicine, 2010, 27(10), 1124-1129. DOI: 10.1111/j.1464-5491.2010.03075.x
Associations between leptin and the leptin / adiponectin ratio and incident Type 2 diabetes in middle-aged men and women: results from the MONICA / KORA Augsburg Study 1984-2002Diabetic Medicine, 2010, 27(9), 1004-1011. DOI: 10.1111/j.1464-5491.2010.03043.x
Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trialDiabetic Medicine, 2010, 27(9), 1024-1032. DOI: 10.1111/j.1464-5491.2010.03020.x
Nurse-led clinics for strict hypertension control are effective long term: a 7 year follow-up studyDiabetic Medicine, 2010, 27(8), 933-937. DOI: 10.1111/j.1464-5491.2010.03039.x
One-year follow-up of untreated obese white children and adolescents with impaired glucose tolerance: high conversion rate to normal glucose toleranceDiabetic Medicine, 2010, 27(5), 516-521. DOI: 10.1111/j.1464-5491.2010.02991.x
The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetesDiabetic Medicine, 2010, 27(5), 589-592. DOI: 10.1111/j.1464-5491.2010.02955.x
Daytime variability of postprandial glucose tolerance and pancreatic B-cell function using 12-h profiles in persons with Type 2 diabetesDiabetic Medicine, 2010, 27(3), 266-273. DOI: 10.1111/j.1464-5491.2010.02949.x
External validation of QDSCORE® for predicting the 10-year risk of developing Type 2 diabetesDiabetic Medicine, 2011, 28(5), 599-607. DOI: 10.1111/j.1464-5491.2011.03237.x
Oxygen (O2) kinetics during early recovery from peak exercise in patients with Type 2 diabetesDiabetic Medicine, 2011, 28(5), 612-617. DOI: 10.1111/j.1464-5491.2011.03229.x
Obesity and Type 2 diabetes; achieving weight lossDiabetic Medicine, 2011, 28(6), 627-627. DOI: 10.1111/j.1464-5491.2011.03319.x
Bariatric surgery: an IDF statement for obese Type 2 diabetesDiabetic Medicine, 2011, 28(6), 628-642. DOI: 10.1111/j.1464-5491.2011.03306.x
The association of physical inactivity with Type 2 diabetes among different ethnic groupsDiabetic Medicine, 2011, 28(6), 668-672. DOI: 10.1111/j.1464-5491.2011.03248.x
An FTO variant is associated with Type 2 diabetes in South Asian populations after accounting for body mass index and waist circumferenceDiabetic Medicine, 2011, 28(6), 673-680. DOI: 10.1111/j.1464-5491.2011.03257.x
DURATION-2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once-weekly exenatideDiabetic Medicine, 2011, 28(6), 705-714. DOI: 10.1111/j.1464-5491.2011.03301.x
Patient-reported outcomes are superior in patients with Type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label studyDiabetic Medicine, 2011, 28(6), 715-723. DOI: 10.1111/j.1464-5491.2011.03276.x
Renin-angiotensin-aldosterone system blockade and urinary albumin excretion in community-based patients with Type 2 diabetes: The Fremantle Diabetes StudyDiabetic Medicine, 2011, 28(7), 849-855. DOI: 10.1111/j.1464-5491.2011.03230.x
Consensus at last? The International Diabetes Federation statement on bariatric surgery in the treatment of obese Type 2 diabetesDiabetic Medicine, 2011, 28(8), 884-885. DOI: 10.1111/j.1464-5491.2011.03354.x
Waist circumference and metabolic risk factors have separate and additive effects on the risk of future Type 2 diabetes in patients with vascular diseases. A cohort studyDiabetic Medicine, 2011, 28(8), 932-940. DOI: 10.1111/j.1464-5491.2011.03318.x
Low incidence of cardiovascular events in Japanese patients with Type 2 diabetes in primary care settings: a prospective cohort study (JDDM 20)Diabetic Medicine, 2011, 28(10), 1221-1228. DOI: 10.1111/j.1464-5491.2011.03347.x
Psychological adjustment to Type 2 diabetes and relationship qualityDiabetic Medicine, 2011, 28(4), 487-492. DOI: 10.1111/j.1464-5491.2010.03214.x
Impact of a chronic care model based on patient empowerment on the management of Type 2 diabetes: effects of the SINERGIA programmeDiabetic Medicine, 2011, 28(6), 724-730. DOI: 10.1111/j.1464-5491.2011.03253.x
Perceived challenges and priorities in co-morbidity management of older patients with Type 2 diabetesDiabetic Medicine, 2011, 28(7), 781-784. DOI: 10.1111/j.1464-5491.2011.03282.x
ROSES: role of self-monitoring of blood glucose and intensive education in patients with Type 2 diabetes not receiving insulin. A pilot randomized clinical trialDiabetic Medicine, 2011, 28(7), 789-796. DOI: 10.1111/j.1464-5491.2011.03268.x
Development and evaluation of a standardized registry for diabetes in pregnancy using data from the Northern, North West and East Anglia regional auditsDiabetic Medicine, 2011, 28(7), 797-804. DOI: 10.1111/j.1464-5491.2011.03259.x
Diabetes Medication Assistance Service Stage 1: impact and sustainability of glycaemic and lipids control in patients with Type 2 diabetesDiabetic Medicine, 2011, 28(8), 987-993. DOI: 10.1111/j.1464-5491.2011.03296.x
Evidence for a dose effect of renin-angiotensin system inhibition on progression of microalbuminuria in Type 2 diabetes: a meta-analysisDiabetic Medicine, 2011, 28(10), 1182-1187. DOI: 10.1111/j.1464-5491.2011.03341.x
Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart diseaseDiabetic Medicine, 2011, 28(10), 1194-1200. DOI: 10.1111/j.1464-5491.2011.03353.x
Impact of biomarkers for endothelial dysfunction and procoagulant state on 10-year cardiovascular risk in Type 2 diabetesDiabetic Medicine, 2011, 28(10), 1201-1205. DOI: 10.1111/j.1464-5491.2011.03311.x
Experience of hypoglycaemia is associated with changes in beliefs about diabetes in patients with Type 2 diabetesDiabetic Medicine, 2011, 28(11), 1395-1400. DOI: 10.1111/j.1464-5491.2011.03340.x
" style="text-decoration:none">Efficacy and safety of linagliptin in persons with Type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized studyDiabetic Medicine, 2011, 28(11), 1352-1361. DOI: 10.1111/j.1464-5491.2011.03387.x
Association and evolutionary studies of the melatonin receptor 1B gene (MTNR1B) in the self-contained population of Sorbs from GermanyDiabetic Medicine, 2011, 28(11), 1373-1380. DOI: 10.1111/j.1464-5491.2011.03374.x
Prevalence, awareness and treatment of type 2 diabetes mellitus in Switzerland: the CoLaus studyDiabetic Medicine, 2012, 29(2), 190-197. DOI: 10.1111/j.1464-5491.2011.03422.x
Family history of diabetes and effectiveness of lifestyle counselling on the cardio-metabolic risk profile in individuals at high risk of Type 2 diabetes: 1-year follow-up of the FIN-D2D projectDiabetic Medicine, 2012, 29(2), 207-211. DOI: 10.1111/j.1464-5491.2011.03388.x
The impact of hypoglycaemia on quality of life and related patient-reported outcomes in Type 2 diabetes: a narrative reviewDiabetic Medicine, 2012, 29(3), 293-302. DOI: 10.1111/j.1464-5491.2011.03416.x
Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitusDiabetic Medicine, 2012, 29(3), 313-320. DOI: 10.1111/j.1464-5491.2011.03429.x
Validity of self-assessed waist circumference in a multi-ethnic UK populationDiabetic Medicine, 2012, 29(3), 404-409. DOI: 10.1111/j.1464-5491.2011.03478.x
Increased serum concentrations of adhesion molecules but not of chemokines in patients with Type 2 diabetes compared with patients with Type 1 diabetes and latent autoimmune diabetes in adult age: Action LADA 5Diabetic Medicine, 2012, 29(4), 470-478. DOI: 10.1111/j.1464-5491.2011.03546.x
Estimated morbidity and mortality in adolescents and young adults diagnosed with Type 2 diabetes mellitusDiabetic Medicine, 2012, 29(4), 453-463. DOI: 10.1111/j.1464-5491.2011.03542.x
Seasonal variations of urinary albumin creatinine ratio in Japanese subjects with Type 2 diabetes and early nephropathyDiabetic Medicine, 2012, 29(4), 506-508. DOI: 10.1111/j.1464-5491.2011.03472.x
Dynamic cerebral autoregulation assessed by respiratory manoeuvres in non-insulin-treated Type 2 diabetes mellitusDiabetic Medicine, 2012, 29(5), 609-613. DOI: 10.1111/j.1464-5491.2011.03497.x
Risk of acute renal failure in patients with Type 2 diabetes mellitusDiabetic Medicine, 2012, 29(5), 614-621. DOI: 10.1111/j.1464-5491.2011.03498.x
C-reactive protein concentration predicts mortality in type 2 diabetes: the Diabetes Heart StudyDiabetic Medicine, 2012, 29(6), 767-770. DOI: 10.1111/j.1464-5491.2011.03560.x
Acceptance of insulin therapy: a long shot? Psychological insulin resistance in primary careDiabetic Medicine, 2012, 29(6), 796-802. DOI: 10.1111/j.1464-5491.2011.03552.x
Low glycaemic variability in subjects with Type 2 diabetes following pre-Ramadan assessment and adjustments for fastingDiabetic Medicine, 2012, 29(6), 828-829. DOI: 10.1111/j.1464-5491.2012.03632.x
Costs of diabetes; new figures for Type 1 and Type 2 diabetesDiabetic Medicine, 2012, 29(7), 835-835. DOI: 10.1111/j.1464-5491.2012.03716.x
The cost of diagnosing Type 2 diabetes mellitus by clinical opportunistic screening in general practiceDiabetic Medicine, 2012, 29(7), 863-868. DOI: 10.1111/j.1464-5491.2012.03607.x
Estimating the potential population impact of stepwise screening strategies for identifying and treating individuals at high risk of Type 2 diabetes: a modelling studyDiabetic Medicine, 2012, 29(7), 893-904. DOI: 10.1111/j.1464-5491.2012.03609.x
Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysisDiabetic Medicine, 2012, 29(7), 933-936. DOI: 10.1111/j.1464-5491.2012.03640.x
Blood glucose testing and primary prevention of Type 2 diabetes-evaluation of the effect of evidence-based patient information: a randomized controlled trialDiabetic Medicine, 2012, 29(8), 1011-1020. DOI: 10.1111/j.1464-5491.2011.03531.x
Effect of exposure to non-esterified fatty acid on progressive deterioration of insulin secretion in patients with Type 2 diabetes: a long-term follow-up studyDiabetic Medicine, 2012, 29(8), 980-985. DOI: 10.1111/j.1464-5491.2011.03566.x
Pedometer-determined physical activity is linked to low systemic inflammation and low arterial stiffness in Type 2 diabetesDiabetic Medicine, 2012, 29(9), 1119-1125. DOI: 10.1111/j.1464-5491.2012.03621.x
Self monitoring of glucose in Type 2 diabetes: guidelines fail to reflect evidenceDiabetic Medicine, 2012, 29(10), 1225-1225. DOI: 10.1111/j.1464-5491.2012.03654.x
Impact of body mass index on the predictive ability of body fat distribution for Type 2 diabetes risk in KoreansDiabetic Medicine, 2012, 29(11), 1395-1398. DOI: 10.1111/j.1464-5491.2012.03661.x
An analysis of the relative risk for hypothyroidism in patients with Type 2 diabetesDiabetic Medicine, 2012, 29(12), 1510-1514. DOI: 10.1111/j.1464-5491.2012.03687.x
Exenatide plus metformin compared with metformin alone on β-cell function in patients with Type 2 diabetesDiabetic Medicine, 2012, 29(12), 1515-1523. DOI: 10.1111/j.1464-5491.2012.03699.x
Intrapersonal HbA1c variability and the risk of progression of nephropathy in patients with Type 2 diabetesDiabetic Medicine, 2012, 29(12), 1562-1566. DOI: 10.1111/j.1464-5491.2012.03767.x
Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre studyDiabetic Medicine, 2012, 29(12), 1556-1561. DOI: 10.1111/dme.12005
Primary prevention of Type 2 diabetes in South Asians - challenges and the way forwardDiabetic Medicine, 2013, 30(1), 26-34. DOI: 10.1111/j.1464-5491.2012.03753.x
A four-stage model explaining the higher risk of Type 2 diabetes mellitus in South Asians compared with European populationsDiabetic Medicine, 2013, 30(1), 35-42. DOI: 10.1111/dme.12016
Alcohol consumption is associated with reduced risk of Type 2 diabetes and autoimmune diabetes in adults: results from the Nord-Trondelag health studyDiabetic Medicine, 2013, 30(1), 56-64. DOI: 10.1111/j.1464-5491.2012.03713.x
Increased dietary fruit intake was associated with lower burden of carotid atherosclerosis in Chinese patients with Type 2 diabetes mellitusDiabetic Medicine, 2013, 30(1), 100-108. DOI: 10.1111/j.1464-5491.2012.03764.x
Taspoglutide, a once-weekly glucagon-like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open-label randomized trialDiabetic Medicine, 2013, 30(1), 109-113. DOI: 10.1111/dme.12003
Genetic variants of LPIN1 indicate an association with Type 2 diabetes mellitus in a Chinese populationDiabetic Medicine, 2013, 30(1), 118-122. DOI: 10.1111/j.1464-5491.2012.03758.x
Insulin degludec improves health-related quality of life (SF-36®) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: a meta-analysis of phase 3a trialsDiabetic Medicine, 2013, 30(2), 226-232. DOI: 10.1111/dme.12086
Banting Memorial Lecture 2012 Reversing the twin cycles of Type 2 diabetesDiabetic Medicine, 2013, 30(3), 267-275. DOI: 10.1111/dme.12039
Longitudinal association between medication adherence and glycaemic control in Type 2 diabetesDiabetic Medicine, 2013, 30(3), 338-344. DOI: 10.1111/dme.12046
Stepwise intensification of insulin therapy in Type 2 diabetes management-exploring the concept of the basal-plus approach in clinical practiceDiabetic Medicine, 2013, 30(3), 276-288. DOI: 10.1111/dme.12019
Retracted: Effects of fasting blood glucose, diabetes treatment, blood pressure and anti-hypertension treatment on cardiovascular disease incidence: a 30-year follow-up study of 740 incident patients with Type 2 diabetesDiabetic Medicine, 2013, 30(3), 349-357. DOI: 10.1111/dme.12106
Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countriesDiabetic Medicine, 2013, 30(4), 387-398. DOI: 10.1111/dme.12119
Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic reviewDiabetic Medicine, 2013, 30(5), 512-524. DOI: 10.1111/dme.12128
Decrease of postprandial endothelial dysfunction by spice mix added to high-fat hamburger meat in men with Type 2 diabetes mellitusDiabetic Medicine, 2013, 30(5), 590-595. DOI: 10.1111/dme.12120
The needs, concerns, and characteristics of younger Australian adults with Type 2 diabetesDiabetic Medicine, 2013, 30(5), 620-626. DOI: 10.1111/dme.12078
The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with Type 2 diabetesDiabetic Medicine, 2013, 30(6), 756-757. DOI: 10.1111/dme.12094
Systematic review of the development, implementation and availability of smart-phone applications for assessing Type 2 diabetes riskDiabetic Medicine, 2013, 30(6), 758-760. DOI: 10.1111/dme.12115
A risk-adjusted economic evaluation of alternative models of involvement of practice nurses in management of type 2 diabetesDiabetic Medicine, 2013, 30(7), 855-863. DOI: 10.1111/dme.12195
Medical strategies to reduce amputation in patients with Type 2 diabetesDiabetic Medicine, 2013, 30(8), 893-900. DOI: 10.1111/dme.12169
Non-linear association between 25-hydroxyvitamin D and the incidence of Type 2 diabetes: a community-based nested case-control studyDiabetic Medicine, 2013, 30(8), 934-938. DOI: 10.1111/dme.12180
Preventing Type 2 diabetes after gestational diabetes: women's experiences and implications for diabetes prevention interventionsDiabetic Medicine, 2013, 30(8), 986-993. DOI: 10.1111/dme.12206
Objective measurements of activity patterns in people with newly diagnosed Type 2 diabetes demonstrate a sedentary lifestyleDiabetic Medicine, 2013, 30(9), 1063-1066. DOI: 10.1111/dme.12199
Relative contributions of insulin resistance and β-cell dysfunction to the development of Type 2 diabetes in KoreansDiabetic Medicine, 2013, 30(9), 1075-1079. DOI: 10.1111/dme.12201
Enhanced carbohydrate craving in patients with poorly controlled Type 2 diabetes mellitusDiabetic Medicine, 2013, 30(9), 1080-1086. DOI: 10.1111/dme.12209
Model of care for the management of complex Type 2 diabetes managed in the community by primary care physicians with specialist support: an open controlled trialDiabetic Medicine, 2013, 30(9), 1112-1121. DOI: 10.1111/dme.12251
Projection of the burden of Type 2 diabetes mellitus in Germany: a demographic modelling approach to estimate the direct medical excess costs from 2010 to 2040Diabetic Medicine, 2013, 30(8), 999-1008. DOI: 10.1111/dme.12177
Trends in selection and timing of first-line pharmacotherapy in older patients with Type 2 diabetes diagnosed between 1994 and 2006Diabetic Medicine, 2013, 30(10), 1209-1213. DOI: 10.1111/dme.12214
Investigation of known estimated glomerular filtration rate loci in patients with Type 2 diabetesDiabetic Medicine, 2013, 30(10), 1230-1235. DOI: 10.1111/dme.12211
A randomized, double-blind, crossover, placebo-controlled trial of 6 weeks benfotiamine treatment on postprandial vascular function and variables of autonomic nerve function in Type 2 diabetesDiabetic Medicine, 2013, 30(10), 1204-1208. DOI: 10.1111/dme.12240
Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trialDiabetic Medicine, 2013, 30(11), 1298-1304. DOI: 10.1111/dme.12303
A randomized crossover study to assess the effect of an oat-rich diet on glycaemic control, plasma lipids and postprandial glycaemia, inflammation and oxidative stress in Type 2 diabetesDiabetic Medicine, 2013, 30(11), 1314-1323. DOI: 10.1111/dme.12228
Urinary C-peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetesDiabetic Medicine, 2013, 30(11), 1342-1348. DOI: 10.1111/dme.12222
Relationship between HbA1c and risk of all-cause hospital admissions among people with Type 2 diabetesDiabetic Medicine, 2013, 30(12), 1407-1411. DOI: 10.1111/dme.12235
The use of technology to promote physical activity in Type 2 diabetes management: a systematic reviewDiabetic Medicine, 2013, 30(12), 1420-1432. DOI: 10.1111/dme.12289
Prevalence of Type 2 diabetes and pre-diabetes among overweight or obese children in Tianjin, ChinaDiabetic Medicine, 2013, 30(12), 1457-1465. DOI: 10.1111/dme.12269
Long-term 4-year safety of saxagliptin in drug-naive and metformin-treated patients with Type 2 diabetesDiabetic Medicine, 2013, 30(12), 1472-1476. DOI: 10.1111/dme.12267
Role of proximal gut exclusion from food on glucose homeostasis in patients with Type 2 diabetesDiabetic Medicine, 2013, 30(12), 1482-1486. DOI: 10.1111/dme.12268
Magnesium intake decreases Type 2 diabetes risk through the improvement of insulin resistance and inflammation: the Hisayama StudyDiabetic Medicine, 2013, 30(12), 1487-1494. DOI: 10.1111/dme.12250
Colesevelam for Type 2 diabetes mellitus: an abridged Cochrane reviewDiabetic Medicine, 2014, 31(1), 2-14. DOI: 10.1111/dme.12295
Waist circumference is genetically correlated with incident Type 2 diabetes in Mexican-American familiesDiabetic Medicine, 2014, 31(1), 31-35. DOI: 10.1111/dme.12266
The optimal morning:evening ratio in total dose of twice-daily biphasic insulin analogue in poorly controlled Type 2 diabetes: a 24-week multi-centre prospective, randomized controlled, open-labelled clinical studyDiabetic Medicine, 2014, 31(1), 68-75. DOI: 10.1111/dme.12322
Is it possible to develop a ‘one-size fits all’ prediction model for undiagnosed Type 2 diabetes?Diabetic Medicine, 2014, 31(1), 116-117. DOI: 10.1111/dme.12292
Social patterning in knowledge following an informed choice invitation for Type 2 diabetes screeningDiabetic Medicine, 2014, 31(4), 504-508. DOI: 10.1111/dme.12334
Increased intestinal permeability to oral chromium (51Cr) -EDTA in human Type 2 diabetesDiabetic Medicine, 2014, 31(5), 559-563. DOI: 10.1111/dme.12360
The relationship between metformin therapy and sleep quantity and quality in patients with Type 2 diabetes referred for potential sleep disordersDiabetic Medicine, 2014, 31(5), 577-580. DOI: 10.1111/dme.12362
The association between BMI and hospitalization for heart failure in 83 021 persons with Type 2 diabetes: a population-based study from the Swedish National Diabetes RegistryDiabetic Medicine, 2014, 31(5), 586-594. DOI: 10.1111/dme.12340
Improving quality of care in people with Type 2 diabetes through the Associazione Medici Diabetologi-annals initiative: a long-term cost-effectiveness analysisDiabetic Medicine, 2014, 31(5), 615-623. DOI: 10.1111/dme.12366
Incidence of Type 2 diabetes among occupational classes in Sweden: a 35-year follow-up cohort study in middle-aged menDiabetic Medicine, 2014, 31(6), 674-680. DOI: 10.1111/dme.12405
Association of fasting glucose with subclinical cerebrovascular disease in older adults without Type 2 diabetesDiabetic Medicine, 2014, 31(6), 691-698. DOI: 10.1111/dme.12385
Erectile dysfunction is a strong predictor of poor quality of life in men with Type 2 diabetes mellitusDiabetic Medicine, 2014, 31(6), 699-706. DOI: 10.1111/dme.12412
Predicting cognitive ability in ageing cohorts using Type 2 diabetes genetic riskDiabetic Medicine, 2014, 31(6), 714-720. DOI: 10.1111/dme.12389
Serum selenium in relation to measures of glucose metabolism and incidence of Type 2 diabetes in an older Swedish populationDiabetic Medicine, 2014, 31(7), 787-793. DOI: 10.1111/dme.12429
Type 2 diabetes mellitus and obesity in young adults: the extreme phenotype with early cardiovascular dysfunctionDiabetic Medicine, 2014, 31(7), 794-798. DOI: 10.1111/dme.12431
Short- and long-term effects of real-time medication monitoring with short message service (SMS) reminders for missed doses on the refill adherence of people with Type 2 diabetes: evidence from a randomized controlled trialDiabetic Medicine, 2014, 31(7), 821-828. DOI: 10.1111/dme.12439
Performance of formulas for estimating glomerular filtration rate in Indigenous Australians with and without Type 2 diabetes: the eGFR StudyDiabetic Medicine, 2014, 31(7), 829-838. DOI: 10.1111/dme.12426
New American College of Cardiology and American Heart Association cholesterol treatment guidelines: subjects with Type 2 diabetes are under treated with high-intensity statinsDiabetic Medicine, 2014, 31(7), 879-880. DOI: 10.1111/dme.12420
Colesevelam for Type 2 diabetes mellitus: an abridged Cochrane reviewDiabetic Medicine, 2014, 31(7), 880-880. DOI: 10.1111/dme.12424
Physical activity in Type 2 diabetes: have we got it correct?Diabetic Medicine, 2014, 31(8), 885-885. DOI: 10.1111/dme.12526
Association of physical activity with glycaemic control and cardiovascular risk profile in 65 666 people with Type 2 diabetes from Germany and AustriaDiabetic Medicine, 2014, 31(8), 905-912. DOI: 10.1111/dme.12438
Cardiovascular risk profiles in relation to newly diagnosed Type 2 diabetes diagnosed by either glucose or HbA1c criteria in Chinese adults in Qingdao, ChinaDiabetic Medicine, 2014, 31(8), 920-926. DOI: 10.1111/dme.12498
Predicting mortality in people with Type 2 diabetes mellitus after major complications: a study using Swedish National Diabetes Register dataDiabetic Medicine, 2014, 31(8), 954-962. DOI: 10.1111/dme.12468
Sex-specific effects of naturally occurring variants in the dopamine receptor D2 locus on insulin secretion and Type 2 diabetes susceptibilityDiabetic Medicine, 2014, 31(8), 1001-1008. DOI: 10.1111/dme.12464
Hepatic steatosis and non-alcoholic fatty liver disease are not associated with decline in renal function in people with Type 2 diabetesDiabetic Medicine, 2014, 31(9), 1039-1046. DOI: 10.1111/dme.12456
Effects of fasting blood glucose levels and blood pressure and treatment of diabetes and hypertension on the incidence of cardiovascular disease: a study of 740 patients with incident Type 2 diabetes with up to 30 years' follow-upDiabetic Medicine, 2014, 31(9), 1055-1063. DOI: 10.1111/dme.12514
Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitusDiabetic Medicine, 2014, 31(9), 1138-1147. DOI: 10.1111/dme.12447
The influence of sex on renal function decline in people with Type 2 diabetesDiabetic Medicine, 2014, 31(9), 1121-1128. DOI: 10.1111/dme.12478